DAY-1: 29TH JANUARY 2007 |
8:00 |
Registration |
9:00 |
Welcome address
D Balasubramanian
Satish Totey |
|
SESSION-I: EMBRYONIC STEM CELLS
Chairperson: Polani Sheshagiri |
9:15-10:00 |
Stephen Minger (UK) |
Special Lecture:
Therapeutic applications of human stem cells – Prospects and challenges |
10:00-10:30 |
Harry Moore (UK) |
Derivation of human embryonic stem cell lines and progress to cGMP standards for clinical applications |
10:30-11.:00 |
William Stanford (Canada) |
Novel networks regulating embryonic stem cell self-renewal and commitment |
11:00-11:45 |
COFFEE BREAK – POSTER PRESENTATION-I |
|
SESSION-II: ADULT STEM CELLS –PART-I
Chairperson: Alok Srivastava
Co-Chair Deepa Bhartiya |
11:45-12:15 |
Virender Sangwan (India) |
Clinical outcome of cultivated limbal epithelium transplantation |
12:15-12:45 |
May Griffith (Canada) |
Restoring vision with stem cells and tissue engineering: Bioengineered corneas |
12:45-13:15 |
Paul Verma (Australia) |
Strategies for overcoming immuno-rejection following stem cell therapy |
13:15 -14:15 |
LUNCH |
|
SESSION-III: ES CELL DIFFERENTIATION
Chairperson: CM Habibullah
Co-chair: Geeta Vemuganti |
14:15-14:45 |
Christine Mummery
(The Netherland) |
Cardiomyocytes from human embryonic stem cells |
14:45-15:15 |
Victoria Browning (USA) |
Differentiation of murine and human ES cells to endoderm and pancreatic lineages |
15:15-15:45 |
MM Panicker (India) |
Early differentiation events can be affected by inhibiting 5-HT2A receptors |
15:45-16:15 |
Maneesha Inamdar (India) |
Dissecting the conserved roles of stem cell gene in cardiovascular development and function |
16:15-16:45 |
Aparna Khanna (India) |
Embryonic stem cells as a tool for predictive toxicology |
16:45-17:15 |
COFFEE BREAK – POSTER PRESENTATION-II |
|
KEY NOTE ADDRESS
Chairperson: MK Bhan |
17:15-17:45 |
Inauguration by Hon’ble Minister Kapil Sibal |
17:45-18:45 |
Inder Verma (USA)
Gene therapy: Medicine of the 21st century |
19:00-Onward |
BANQUET DINNER: GEOFFREY LAWN, HOTEL ROYAL ORCHID |
|
END OF DAY-1 |
| DAY-2: 30TH JANUARY 2007 |
|
SESSION-IV: ADULT STEM CELLS-PART-II
Chairperson: Shiv Sarin
Co-Chair: Jyotsna Dhawan |
8:30-9:15 |
Henry Young
(USA) |
Special Lecture:
Adult precursor cells: Progenitor cells and stem cells |
9:15-9:45 |
Malcolm Alison
(UK) |
Liver stem cells |
9:45-10:15 |
Mark Johnston
(USA) |
Isolation of human liver stem cells and use of human liver cells as an alternative to organ transplant |
10:15-10:45 |
Shahragim Tajbakhsh (France) |
Skeletal muscle stem cells |
10:45-11:15 |
Alan Trounson
(Australia) |
Stem cell and regenerative medicine |
11:15-11:45 |
COFFEE BREAK – POSTER PRESENTATION-III |
|
SESSION-V: CANCER STEM CELLS
Chairperson: Vinod Kochupillai
Co-chair K Satyamoorthy |
11:45-12:15 |
Annapoorni
Rangarajan
(India) |
Stem cells and breast cancer |
12:15-12:45 |
Fiona Watt
(UK) |
Role of intracellular communication in regulating tumour formation in mammalian epidermis |
12:45-13:15 |
Connie Eaves
(Canada) |
Mammary tumor stem cells |
13:15-14:45 |
LUNCH |
|
SESSION-VI: ORAL PRESENTATIONS OF SELECTED ABSTRACTS
Chairperson: Subeer Majumdar
Co-chair: Shrikrishna Dadke |
| 14:45-14:30 |
O1 Geeta Vemuganti |
Histocompatibility testing for immunogenic potential of cultivated human bone marrow stromal cells |
| 14:30-14:45 |
O2 Sangeetha V M |
Improved ex-vivo expansion of cord blood derived C34+ cells in serum-free medium containing cytokines supplemented with anti-apoptotic agents |
| 14:45-15:00 |
O3 Mahesh Verma |
ES cells and cardiomyogenesis: The role of Wnt signaling |
| 15:00-15:15 |
O4 R. Udayshankar |
The potential of different human embryonic stem cell lines to generate trophoblast and their function in co-culture with human endometrium |
| 15:15-15:30 |
O5 Pallavi Gupta |
Stem cell differentiation control by transcription factor PU.1: Potential effects of its native & engineered forms in human bone marrow CD34+ cells |
| 15:30-15:45 |
O6 Chetan Shatapathy |
Generation of cardiac stem/progenitor cells - Potential for therapeutic application |
|
SESSION-VII: TISSUE ENGINEERING
Chairperson: |
15:45-16:15 |
Prabha Nair
(India) |
Materials and designs for tissue engineering with stem cells |
16:15-16:45 |
Samuel Abraham
(Japan) |
Culturing, tissue engineering and re-implantation of stem cells using cell/tissue specific hybrid biomaterials |
16:45 -17:15 |
COFFEE – POSTER PRESENTATION-IV |
14:00-16:00 |
PANEL DISCUSSION: TASK FORCE MEMBERS OF DBT AND INVITED GUESTS (parallel session at Autumn Hall, Mezzanine Floor) |
17:15-
Onward |
CULTURAL PROGRAM AND DINNER AT CIE LAWN, CUNNINGHAM ROAD, BANGALORE |
|
END OF DAY-2 |
| DAY-3: 31ST JANUARY 2007 |
| |
SESSION-VIII: MESENCHYMAL AND HEMATOPOETIC STEM CELLS
Chairperson: NK Mehra
Co-chair: Soniya Nityanand |
8:00-8:45 |
Olle Ringden (Sweden) |
Special Lecture:
Immunomodulatory effects of mesenchymal stem cells |
8:45-9:15 |
Tsvee Lapidot
(Israel) |
Osteoclasts degrade endosteal components and promote stem cell egress and mobilization |
9:15-9:45 |
Moustapha Kassem (Denmark) |
Human mesenchymal (skeletal) stem cell: Basic biology and clinical applications for bone tissue regeneration |
9:45-10:15 |
Mohan Wani
(India) |
Commitment of osteoclast precursors towards macrophage lineage by IL-3 through down-regulation of RANK expression |
10:15-10:45 |
Sudhir Krishna
(India) |
Notch signaling based therapies in stem cells and cancer |
10:45-11:15 |
COFFEE - POSTER PRESENTATION-V |
|
SESSION-IX: MESENCHYMAL AND HEMATOPOIETIC STEM CELLS
Chairperson: SS Agarwal
Co-chair: AN Bhisey |
11:15-11:45 |
Arun Srivastava (USA) |
Obstacles to gene transfer in hematopoietic stem cells by recombinant AAV vectors |
11:45-12:15 |
Asok Mukhopadhya (India) |
Can epithelial cells of the liver and kidney regenerate from bone marrow cells? |
12:15-12:45 |
B.S. Ramakrishna (India) |
Treatment of inflammatory bowel disease with mesenchymal stem cells in the mouse model |
12:45-13:30 |
LUNCH |
|
SESSION-X: COMMERCIALIZATION / BANKING
Chairperson: Abhay Kumar
Co-chair: RS Nadig |
13:30.14:00 |
Mahendra Rao
(USA) |
Stem to stem cell therapy: company perspective |
14:00-14:30 |
Tim Allsopp
(UK) |
Putting to practise invention from discovery: commercialization of stem cell research |
14:30-15:00 |
Alan Coleman (Singapore) |
Stem cells: From bench to bedside to bank |
15:00-15:30 |
Glyn Stacey
(UK) |
Challenges for the delivery of clinical grade stem cell lines |
15:30-15:50 |
Robert Balderas
(USA) |
Novel flow cytometric techniques for analysis of protein phosphorylation and signaling networks in stem cell populations |
15:50-16:20 |
COFFEE |
|
SESSION-XI: ORAL PRESENTATION OF SELECTED ABSTRACTS
Chairperson: Sujata Mohanty |
| 16:20-16:35 |
O7 Neeraj Kumar |
Derivation of human embryonic stem cell lines under xeno-free environment |
| 16:35-16:50 |
O8 Jeevisha Bajaj |
Notch-Wnt cross-talk in haematopoietic stem cells |
| 16:50-17:05 |
O9 K. Udaykumar |
Efficient culture system for human embryonic stem cells in a xeno-free culture conditions in absence of bFGF |
| 17:05-17:20 |
O10 Gypsy Long |
Native pancreatic islets co-cultured with totipotent stem cells derived from adult rats demonstrate enhancement of insulin synthesis and secretion in response to a glucose challenge |
17:20-Onward |
DINNER SPONSORED BY BRITISH COUNCIL AT MANIPAL COUNTY, BANGALORE |
|
END OF DAY-3 |
| DAY-4: 1ST FEBRUARY 2007 |
|
SESSION-XII: TRANSLATIONAL RESEARCH
Chairperson: TC Anandkumar
Co-chair: Nagendra Swamy |
8:30-9:15 |
John Martin
(UK) |
Special Lecture:
The unique difficulties of translating basic biology to clinical use in stem cell repair of the heart |
9:15-9:45 |
NK Venkataramana (India) |
Mesenchymal stem cell clinical trial for spinal cord injury |
9:45-10:15 |
Kerry Atkinson (Australia) |
Preclinical and clinical studies of mesenchymal stem cells |
10:15-10:45 |
Akhil Banerjea
(India) |
Derivation of human hematopoietic stem cells resistant to HIV-1 challenge |
10:45-11:15 |
Ramesh Bhonde (India) |
Islet neogenesis from pancreatic and extra pancreatic source of stem cells |
11:15-11:30 |
COFFEE |
|
SESSION-XIII: GUIDELINES AND REGULATIONS
Chairperson: Nagasubramaniam |
11:30-12:00 |
Donald Fink
(USA) |
Embryonic stem cell-based therapies: US-FDA regulatory expectations |
12:00-12:30 |
Linda Powers
(USA) |
Regulation and investment |
12:30-13:00 |
Vasantha Muthuswamy
(India) |
Indian stem cell guidelines and regulation |
13:00-13:30 |
Concluding Remarks and Valedictory Function
Alok Srivastava |
13:30-Onward |
LUNCH |
|
END OF DAY-4 |
